• Return to Headlines

Vanda Pharmaceut is Among the Companies in the Biotechnology Industry With the Highest Future Earnings Growth (VNDA, BMRN, AMAG, GHDX, PDLI)

By Shiri Gupta

Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.

Vanda Pharmaceut ranks highest with a future earnings growth of 221.5%. Following is Biomarin Pharmac with a future earnings growth of 191.3%. Amag Pharmaceuti ranks third highest with a future earnings growth of 116.3%.

Genomic Health I follows with a future earnings growth of 111.4%, and Pdl Biopharma In rounds out the top five with a future earnings growth of 84.9%.

SmarTrend is tracking the current trend status for Vanda Pharmaceut and will alert subscribers who have VNDA in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest future earnings growth vanda pharmaceut biomarin pharmac amag pharmaceuti genomic health i pdl biopharma in

Ticker(s): VNDA BMRN AMAG GHDX PDLI